SAM
RGNX icon

Smartleaf Asset Management’s Regenxbio RGNX Stock Holding History

Smartleaf Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5
Closed -$36 – 2974
2024
Q4 		$36 Sell
5
-847
-99% -$7.95K ﹤0.01% 2908
2024
Q3 		$9.2K Buy
852
+755
+778% +$9.2K ﹤0.01% 1801
2024
Q2 		$1.13K Buy
+97
New +$1.51K ﹤0.01% 2388

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Smartleaf Asset Management's RGNX Position: Q1 2025 in Review

Smartleaf Asset Management sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 5 shares — an estimated $36 sold.

Smartleaf Asset Management first reported a position in RGNX in Q2 2024 and held it in 3 quarters. The position peaked at $9.2K in Q3 2024. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

  • Smartleaf Asset Management reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
  • Smartleaf Asset Management sold 5 Regenxbio shares in Q1 2025, an estimated $36.
  • Smartleaf Asset Management first reported a position in Regenxbio in Q2 2024 and held it in 3 quarters.
  • Smartleaf Asset Management's Regenxbio position peaked at $9.2K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on Smartleaf Asset Management's 13F filing for Q1 2025, filed 14 May 2025.